MCM
MTEM

Moore Capital Management’s Molecular Templates, Inc. MTEM Stock Holding History

Moore Capital Management’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,333
Closed -$270K – 325
2018
Q3 		$270K Buy
+3,333
New +$256K 0.01% 268

Other funds holding MTEM

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Moore Capital Management's MTEM Position: Q4 2018 in Review

Moore Capital Management sold out of Molecular Templates, Inc. (MTEM) in Q4 2018, closing a stake of 3,333 shares — an estimated $270K sold.

Moore Capital Management first reported a position in MTEM in Q3 2018 and held it in 1 quarter. The position peaked at $270K in Q3 2018. 62 funds tracked by Wall St. Rank hold MTEM as of Q4 2018.

  • Moore Capital Management reported no remaining Molecular Templates, Inc. position as of Q4 2018 after selling out during the quarter.
  • Moore Capital Management sold 3,333 Molecular Templates, Inc. shares in Q4 2018, an estimated $270K.
  • Moore Capital Management first reported a position in Molecular Templates, Inc. in Q3 2018 and held it in 1 quarter.
  • Moore Capital Management's Molecular Templates, Inc. position peaked at $270K in Q3 2018.
  • 62 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q4 2018.

Based on Moore Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.